Rafael Holdings, Inc.
Pharmaceutical Preparations · Newark, NJ, United States
- PrincipalsDavid PolinskyChief Financial OfficerHoward S JonasExec Chairman, CEO & Presidentand 4 more
- CompanyRafael Holdings, Inc.Newark, NJ, United States
- Phone line+1 (212) 658-1450General business
Rafael Holdings, Inc. is an SEC-registered NYSE-listed company (ticker RFL) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 6
Chief executive
Howard S JonasExec Chairman, CEO & President
Chair & board
Alan GraysonDirector (Board)
Mark N SteinDirector (Board)
Markus SiegerDirector (Board)
Michael J WeissDirector (Board)
Finance
David PolinskyChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Howard S Jonas — Exec Chairman, CEO & President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Alan Grayson — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Mark N Stein — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David Polinsky — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Mereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityJazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capability